Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US Federal Circuit Pauses Teva, Apotex After Hetlioz Patent Win
Vanda’s Tasimelteon Molecule Patent Expired ‘Just Last Week’
Dec 19 2022
•
By
Dean Rudge
Vanda strongly challenged the lower court's findings • Source: Vegorus
More from Legal & IP
More from Generics Bulletin